英文名称: |
Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate(2:2:1), (3S,4R)- |
英文别名: |
Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate(2:2:1), (3S,4R)-;Paroxetine hydrochloride hemihydrate;Paroxetine (hydrochloride hemihydrate);Paroxetine HCl;Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride, hydrate(2:2...;BRL29060 hydrochloride hemihydrate;BRL29060A hemihydrate;PAROXETINE HEMIHYDRATE, EP;Paroxetine hydrochl;Paroxetine hydrochloride;PAROXETINE-D4 HCL;USP;(3S-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride hemihydrate;(3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride Hemihydrate;(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine hydrochloride hemihydrate;PAROXETINE HCL HEMIHYDRATE;Paroxetine-D4 hydrochloride;PAROXETINE HYDROCHLORIDE 1/2H2O;paroxetine hydrochloride hydrate;Paroxetine Hydrochloride (350 mg);PAROXETINE HEMIHYDRATE, EP/BP/USP;PAROXETINE HYDROCHLORIDE HEMIHYDRATE;Paroxetine hydrochloride hemihydrate, >=99%;Paroxetine Hydrochloride (350 mg)G0D0030.972mg/mg(ai) |
中文别名: |
盐酸帕罗西汀半水合物;5,7-二溴-8-羟基喹啉;Paroxetine Hydrochloride Hemihydrate 盐酸帕罗西汀半水合物;半水帕罗西汀;盐酸帕罗西汀;盐酸帕罗西汀 USP标准品;盐酸帕罗西汀 标准品;(-)-反式-4-(4-氟苯基)-3-{[3,4-(亚甲二氧基)苯氧基]甲基}-哌啶盐酸盐;(-)-反式-4R-(4-氟苯基)-3S-{[3',4'-(亚甲二氧基)苯氧基]甲基}-哌啶盐酸盐半水合物;(3S,4R)-(-)-3-[(1,3-苯并二恶茂-5-基氧)甲基]-4-(4-氟苯基)哌啶盐酸盐;帕罗西汀,盐酸D4;(3S,4R)-(-)-3-[(1,3-苯并二恶茂-5-基氧)甲基]-4-(4-氟苯基)哌啶盐酸盐 半水合物;帕罗西汀盐酸盐半水合物;D4-盐酸帕罗西汀;盐酸帕罗西汀半水合物, 选择性5-羟色胺重吸收抑制剂 (SSRI) |
CAS No.: |
110429-35-1 |
分子式: |
C38H42F2N2O7 |
分子量: |
676.75 |
纯度: |
98% |